Cancer clinical trials in the region Provence-Alpes-Côte d'Azur

398 currently recruiting clinical trials

Looking for clinical trials?

Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:

Create your account
Copy-paste your latest medical report
Our AI-based assistant does the rest for you

Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:

Create your account

Phase 3 Kidney cancer #NCT07489495 #2024-516993-31-00

[LITESPARK-034] Étude clinique du belzutifan (MK-6482) et du zanzalintinib chez les personnes atteintes d'un carcinome à cellules rénales (CCR)

Clear cell carcinoma Metastatic 1 2 3 or more Immunotherapy

Systemic Treatment-Naive

2 recruiting sites

Merck Sharp & Dohme LLC

Phase 3 Bladder / Urinary Tract / Urethral cancer #NCT05024773 #2024-512568-72-00

[PACLITAXEL-ACIDE HYALURONIQUE] Étude de l'ONCOFID-P-B

Non-invasive bladder cancer Urothelial carcinoma Localized 1 Surgery Immunotherapy

Systemic Treatment-Naive

5 recruiting sites

Fidia Farmaceutici s.p.a.

Phase 3 Thyroid and adrenal gland cancer #NCT04290663 #2024-514603-34-00

Administration systématique d'iode radioactif versus décision de traitement par iode radioactif guidée par un bilan postopératoire

Thyroid cancer Differentiated carcinoma Localized None Systemic Treatment-Naive Surgery

Radioactive iodine

28 recruiting sites

Centre François Baclesse

Phase 3 Thyroid and adrenal gland cancer #NCT03583710

Mitotane avec ou sans cisplatine et étoposide après chirurgie dans le traitement des patients atteints d'un cancer corticosurrénalien de stade I à III présentant un risque élevé de récidive

Adrenal gland cancer Adrenocortical carcinoma Localized None Systemic Treatment-Naive Surgery

Chemotherapy Radiotherapy Mitotane

10 recruiting sites

M.D. Anderson Cancer Center

Phase 3 Lung cancer #NCT04613596 #2023-508922-83-00

[KRYSTAL-7] Essai sur l'ADAGRASIB en association chez des patients présentant une mutation KRAS G12C

NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic KRAS G12C PDL1 Positive (>= 50%) None Systemic Treatment-Naive

16 recruiting sites

Mirati Thérapeutique Inc.

Phase 3 Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN) #NCT06465953 #2023-510155-37

[PyramIDH] Monothérapie par ivosidénib (IVO) et monothérapie par azacitidine (AZA) chez les patients atteints de syndromes myélodysplasiques (SMD) naïfs aux agents hypométhylants (AHM) et porteurs d'une mutation IDH1

Myelodysplastic syndromes (MDS) MDS de novo Secondary MDS IDH1/2 None Low Moderately low Moderately high High Very high

Chemotherapy Allogeneic stem cell transplant

6 recruiting sites

Servier

Phase 3 Colon cancer Rectal cancer Anal cancer Pancreas cancer Liver and bile duct cancer Stomach and esophageal cancer Small intestine and appendix cancer #NCT07087054 #2024-519875-24-00

[CAREFNDR] Étude d'efficacité portant sur un schéma posologique quotidien de PALTUSOTINE par voie orale dans le traitement du syndrome carcinoïde